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Abstract
Background: Ovarian cancer is the fifth most common cause of cancer death among women in 
the United States. Failure to receive optimal treatment and poorer survival rates have been reported 
for older women, African-American women, women with low income, and women with public 
health insurance coverage or no coverage. Additionally, regional differences in geographic access 
influence the type of treatment women may seek. This paper explores geographic accessibility and 
sociodemographic vulnerability in Georgia, which influence receipt of optimal ovarian cancer 
treatment.
Methods: An enhanced two-step floating catchment area (E2SFCA), defining physical access, 
was created for each census tract and gynecologic oncologist clinic. Secondly, sociodemographic 
variables reflecting potential social vulnerability were selected from U.S. Census and American 
Community Survey data at the tract level. These two measures were combined to create a measure 
of Geosocial Vulnerability. This framework was tested using Georgia ovarian cancer mortality 
records.
Results: Geospatial access was higher in urban areas with less accessibility in suburban and rural 
areas. Sociodemographic vulnerability varied geospatially, with higher vulnerability in urban citers 
and rural areas. Sociodemographic measures were combined with geospatial access to create a 
Geosocial Vulnerability Indicator, which showed a significant positive association with ovarian 
cancer mortality.
Conclusions: Spatial and sociodemographic measures pinpointed areas of healthcare access 
vulnerability not revealed by either spatial analysis or sociodemographic assessment alone. 
Whereas lower healthcare accessibility in rural areas has been well described, our analysis shows 
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considerable heterogeneity in access to care in urban areas where the disadvantaged census tracts 
can be easily identified.
Keywords
Ovarian cancer; geosocial vulnerability; Geographic Information Systems; social vulnerability; 
two-step floating catchment area
Introduction
Ovarian cancer is the fifth most common cause of cancer death among women in the United 
States (1). Although advances in ovarian cancer treatment over the past several decades have 
led to improvements in survival, this benefit has not been realized for all populations. 
Among the factors that influence improved outcomes for ovarian cancer are optimal surgical 
treatment by a gynecologic oncologist, treatment in a high-volume hospital, and guideline-
compliant treatment (2–4). Failure to receive optimal treatment and poorer survival rates 
have been reported for older women, African-American women, women with low income, 
and women with public health insurance coverage or no coverage (5–9). The role of 
geography in explaining disparities also has been explored. Regional differences in 
treatment, as well as urban-rural differences, and long travel distances, have been shown to 
influence the receipt of surgery or chemotherapy for ovarian cancer (4,7,10). Thus, 
particularly vulnerable populations experience spatial and/or sociodemographic barriers to 
ovarian cancer treatment.
Whereas this research demonstrates the importance of factors such as education and income 
as well as healthcare location and travel time in accessing optimal care, there has also been a 
growing interest in finding ways to integrate the spatial and non-spatial factors into a single 
framework. Recognizing that access to healthcare is a multidimensional construct (11,12), 
the aim here is to consider both spatial characteristics and socio-contextual variables in a 
way that provides a more comprehensive view of access to healthcare. Some advantages of a 
single access framework might include ease in interpreting maps or summary outcome 
measures and enabling the ability to identify specific geographic areas and populations with 
particularly high barriers to healthcare access for policy or program interventions. 
Challenges in creating an integrative measure include developing methods of aggregating 
sociodemographic variables and establishing a simple but effective process of consolidating 
spatial and non-spatial characteristics (13).
A number of new approaches advance our understanding of the role of geographic location 
in health care access since Penchansky and Thomas outlined a conceptual model of access to 
care (11). These have used multivariate or multilevel modeling to integrate spatial and 
sociodemographic characteristics based on patient-level data. An examination of colorectal 
cancer testing using multilevel models that included county-level sociodemographic 
characteristic, patient-level data, and distance to testing facilities found that patients with the 
longest travel distance were least likely to undergo testing (14).
Recent geographical approaches to identifying vulnerable populations have examined both a 
spatial accessibility component as measured by travel time or distance to services, and a 
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sociodemographic component including factors such as income, ethnicity, race, age, and 
health insurance status. Spatial regression models have been used to incorporate both sets of 
factors to examine access to mammography facilities in Chicago, Illinois (15), and 
multilevel modeling used to combine demographic and community structural factors in 
describing regional differences in colorectal cancer screening (14). Bristow and colleagues 
(16) used individual level patient data, patient distance to hospitals having a high volume of 
ovarian cancer cases, and census block-level socioeconomic status (SES) data in generalized 
additive models to obtain odds of adherence to optimal treatment for ovarian cancer. Travel 
distance and proximity to facilities treating a high volume of ovarian cancer patients were 
predictive of receiving guideline-adherent treatment (16). Wang and Luo (13) conducted a 
study of access to primary care to demonstrate a method to integrate spatial and 
sociodemographic characteristics into one framework. They used a two-step floating 
catchment area method and factor analysis of demographic characteristics to identify and 
map tracts with socioeconomic disadvantage, sociocultural barriers, and high health care 
needs. Spatial accessibility and socioeconomic factors were combined to identify specific 
tracts with high physician shortages.
Building upon this current line of research, we demonstrate a method that considers spatial 
and sociodemographic factors separately, as well as combined geosocial vulnerability, to 
measure access to ovarian cancer care by a gynecologic oncologist. In our approach, we 
used available tract-level census data and standard GIS techniques (including geocoding, 
network analysis, and E2SFCA) to measure gynecologic oncologist supply and population 
demand in a method that is relatively easy to implement. Key inputs in this analysis are 
sociodemographic characteristics that can influence medical care seeking and receipt of 
optimal care. Thus, our approach combines spatial and non-spatial factors using a 
reasonably simple process (13). We then test the association between our geosocial 
vulnerability score using ovarian mortality rates in Georgia, US.
Methods
Measuring access to gynecologic oncologists
The enhanced two-step floating catchment area (E2SFCA), introduced by Luo and Qi (17) 
has been used to measure spatial accessibility that incorporates both supply and demand. 
This method calculates a population-to-provider ratio within a specified catchment area, in 
this case defined by travel time. To account for diminishing accessibility that occurs with 
increasing distance within a catchment area, we weighted two travel time zones within each 
catchment, giving a lower accessibility measure for the zone with longer travel times. 
Compared to other methods used to measure spatial accessibility, such as basic provider-to-
population ratios or travel time impedance, researchers have found E2SFCA to be optimal 
for measuring healthcare access for both rural and urban populations over large geographic 
areas (18,19).
We used the E2SFCA to calculate the spatial accessibility of gynecologic oncologists in 
Georgia. First, we created catchment areas for each of Georgia’s twenty gynecologic 
oncologist clinics. Clinic street address locations were obtained from the Society for 
Gynecologic Oncology website (https:/www.sgo.org/seek-a-specialist/). One of the authors 
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(LP) contacted offices for address verification. Addresses were geocoded using Pitney 
Bowes’ Centrus geocoding tool (Centrus Desktop, version 6.0). Sixty-minute street network 
drive time catchments from each clinic were created using NAVTEQ 2010 streets and Esri’s 
Network Analyst (ArcGIS 10.3). We chose a 60-minute catchment size to accommodate 
urban, suburban, and rural driving distances within this mid-sized state. Each 60-minute 
catchment was subdivided into two travel time zones, 0 to 30 minutes and greater than 30 to 
60 minutes. For these two time zones, we applied a weight to account for distance decay 
within the 60-minute time zone. Due to the nature of accessing specialty cancer care 
facilities we chose a slow decay function to assign the zonal weights (17). Therefore, the 0–
30-minute zone was assigned a weight of 1.0; the >30–60-minute zone, 0.8.
To calculate the population-to-provider ratio, we used the Geospatial Research Analysis and 
Services Program (GRASP) Population Estimator tool to estimate the number of women 15 
years of age and older within each travel time zone (20). The tool applies an area proportion 
technique that assumes an equal population distribution within each census tract. The 
population of each tract is multiplied by the proportion of the tract area that falls within the 
travel time zone. The resulting tract population totals and proportions were summed to 
determine a population total for the zone. The population totals were then adjusted by the 
weight assigned for each travel time zone. To reach a provider-to-population ratio for each 
clinic, the number of physicians at each location were summed and divided by the weighted 
population estimates for each zone (17).
For the second step of the E2SFCA, we summed the ratios created in step one for each clinic 
that fell within the travel time zones from each population center. To do this, population-
weighted centroids were calculated at the census tract level using 2010 Census block 
population data for women 15 years of age or older. Sixty-minute catchments were created 
for each weighted centroid, with the two travel zones of 0–30, and 30–60 minutes. The sum 
of the ratios was weighted for each zone, using the same zonal multipliers as in step one, 
giving each tract an accessibility score ranging from 0.0 (no accessibility) to 1.6 (high 
accessibility) per 1,000 women.
Measuring geosocial vulnerability
Wang and Luo (13) provided a methodological framework for modeling geosocial 
vulnerability. We based our choice of sociodemographic characteristics on prior research 
identifying factors associated with ovarian cancer outcomes such as income, poverty, race, 
and education level (4,9). Because the percentage of ovarian cancer deaths is highest among 
women 65 to 74 years of age (21), we included Census 2010 100% count data (SF1) 
percentage of residents age 65 and older (www.census.gov). In addition, we included the 
following American Community Survey (ACS), 2006–2010 variables: percentage of persons 
below the poverty level, and percentage of persons with no high school diploma for persons 
aged 25 and older (www.census.gov).
The indicator ‘residents age 65 and older’ was selected as the incidence of ovarian cancer 
increases substantially with age. Because ovarian cancer is more frequently diagnosed in 
white women than black women, we have excluded minority status as an informative 
variable (https://www.cdc.gov/cancer/ovarian/statistics/race.htm). We selected two census 
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variables for which Georgia ranks in the bottom quintile of the nation—poverty, an indicator 
likely varying geographically within the state—and the absence of a high school diploma. 
These two variables are associated with having less social capital; that is, social networks 
that are less likely to provide awareness of the disease and options for seeking treatment. 
These three variables are positively associated with ovarian cancer mortality and statistically 
significant at P<0.001.
We identified the census tracts in Georgia that were one standard deviation above the mean 
for any of the three selected sociodemographic census variables. These tracts (N=653) were 
deemed socially vulnerable. The 360 tracts with low geographic accessibility (E2SFCA 
score of 0.0) were flagged as spatially vulnerable. Combined geosocial vulnerability 
indicates tracts that presented with both a geographic accessibility of 0.0 and were one 
standard deviation above the mean in any of the sociodemographic variables. We identified 
341 tracts (17.4%) as combined geosocially vulnerable tracts.
Measure testing
Georgia ovarian cancer mortality records for Malignant Neoplasm of Ovary (ICD-10-CM 
C56) for the years 2005–2013 were obtained from the Georgia Department of Public Health 
(Georgia Department of Public Health, Georgia Ovarian Cancer Mortality Data). Mortality 
records had been geocoded to the street address level and then aggregated to census tract. 
We calculated raw ovarian cancer rates per 10,000 women for an eight-year period (2005–
2013) using ovarian cancer mortality and female population 15 years of age and older by 
census tract. Total tract population varies considerably across the state, and such variability 
lends to a small numbers problem when analyzing clustering in health data. To overcome the 
varying degrees of reliability associated with small numbers, and because calculations with 
small counts can result in unstable raw mortality rates, we investigated two mapping 
techniques: probability mapping and spatial empirical Bayes smoothing (22).
We used the Poisson distribution method, which models the probability of rare binary events 
(e.g., ovarian cancer deaths), to determine if the number of deaths in a given census tract is 
significantly different than expected based on the state mortality rate. In other words, the 
Poisson test models the likelihood that the calculated tract mortality rates indicate a higher 
or lower probability than the expected state mortality rate. Poisson values closer to zero 
indicate a higher than expected mortality rate. Because probability mapping may 
overemphasize the significance of areas with large populations, we also explored spatial 
empirical Bayes estimation, which “represents a compromise between probability mapping 
and simple choropleth mapping of rates” (22). Bayesian smoothing adjusts mortality rates 
for individual tracts, depending on population size, while maintaining the overall state rate. 
We applied the empirical Bayes smoothing technique using a 1st order queen contiguity 
weighting scheme and a non-informative prior in GeoDa (23). Empirical Bayesian 
smoothing focuses on areas with high margins of error, moving these estimates closer to the 
local global average of the event rate. The raw rates (non-smoothed) have not been adjusted. 
Both raw and smoothed rates had relatively normal distributions.
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Results
Geosocial vulnerability
Figure 1A displays the results of the E2SFCA. The map shows generally higher accessibility 
in urban areas, and concentrically less accessibility in suburban and rural areas. One 
exception is tracts in the vicinity of the sole clinic in Athens in northeastern Georgia where 
higher population and a single oncologist results in a lower accessibility ratio. In contrast, 
Gainesville, also in the northeastern part of the state, has one provider but a much lower 
accessibility ratio. Most of the balance of the state, consisting of rural areas and smaller 
cities, has an accessibility score of 0.00 (low accessibility).
Figure 1B shows an additional measure of geographic variation within the state: that of 
sociodemographic vulnerability. Instead of an urban-rural continuum, the results indicate a 
suburban effect around major population centers (e.g., Columbus, Savannah, Athens, & 
Augusta), with high vulnerability at the city center and less vulnerability on the periphery. In 
Atlanta, higher vulnerability is especially apparent in the southern part of the city. The 
remainder of the state, including both smaller cities and extensive rural areas, displays more 
variability in social vulnerability than is seen in spatial accessibility. The combined results of 
our measure of low geographic accessibility and high social vulnerability are represented in 
Figure 2, alongside higher than expected mortality rates. Low accessibility in areas remote 
from a clinic combined with high social vulnerability produce many tracts throughout the 
state that are doubly challenged with regard to access to gynecological oncologists.
Ovarian cancer mortality
Figure 3 presents maps of ovarian cancer mortality in Georgia; raw ovarian mortality rates 
(Figure 3A), and empirical Bayes smoothed ovarian mortality rates (Figure 3B). 
Additionally, both maps show areas of significantly high mortality rates calculated by the 
Poisson distribution test. Figure 3A shows overall spatial variability in areas of high and low 
raw mortality rates. Figure 3B, presenting smoothed mortality rates based on the size of the 
total tract population, shows less variability spatially. The raw rates and smoothed mortality 
rates were moderately correlated with each other (r=0.69) as well as with the Poisson 
probability distributions (0.929, 0.651 for raw and smoothed respectively). A paired t-test 
indicated no statistically significant difference between the two rates, thus providing 
validation for the stabilized smoothed rates. The difference in the results between the raw 
and smoothed rates is due to the smoothed rates being more geographically stable than the 
raw rates. The process yields tract rates that are closer to the local geographical average as 
opposed to the raw rate, which can vary considerably across tracts. Tracts identified by 
Poisson probability analysis as having significantly higher than expected mortality are 
presented alongside the geosocial vulnerability in Figure 2. These tracts are moderately 
distributed across the state but appear to correspond with those tracts having joint 
vulnerabilities.
Table 1 depicts the results of the geosocial vulnerability measure for ovarian cancer 
mortality at the census tract level. Out of 82 tracts flagged with significantly high mortality, 
75% (N=61) fell into one of the three vulnerability designations. Tracts exhibiting both high 
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social vulnerability and low geographic accessibility, defined as geosocially vulnerable, 
accounted for 37% (N=30) of the high mortality tracts.
Discussion
Results from this analysis illustrate that highlighting both spatial and sociodemographic 
vulnerabilities can identify areas of healthcare access vulnerability not revealed by either 
spatial analysis or sociodemographic assessment alone. Whereas lower healthcare 
accessibility in rural areas has been well described, our maps also show considerable 
heterogeneity in access to care in urban areas where the disadvantaged census tracts can be 
easily identified. This type of analysis may be especially useful in urban areas where 
transportation distances are shorter but sociodemographic barriers to care limit what 
otherwise appears to be an adequate population to specialist ratio. Our findings are 
consistent with studies that have described urban disadvantages in cancer screening, 
diagnosis, and treatment (14,15,24–26). Importantly, we were also able to show that the 341 
tracts exhibiting combined geosocial vulnerability represented 37% of tracts with high 
ovarian cancer mortality.
Despite a small decline in both incidence and mortality rates over the past two decades, 5-
year survival remains relatively low (21,27) and without advances in screening or preventive 
measures, treatment with optimal surgery and chemotherapy offers best potential for long 
term survival (28,29). That poverty plays a role in access to care and mortality is recognized 
across many health outcomes. Education level may reflect knowledge about the best 
treatment for ovarian cancer or the need for specialist care as well as financial resources. 
Our findings of the association between mortality and high geosocial vulnerability suggest 
characteristics such as poverty and low education levels, as well as distance, impede access 
to that care.
We note several limitations in our study. Ours is an ecologic analysis that describes the 
geosocial vulnerabilities of women in a census tract with respect to medical specialist 
proximity. Thus, we are referring to a hypothetical patient in that tract for whom we have no 
individual level characteristics. Access to care is a multifactorial construct encompassing 
complex relationships between spatial supply of specialists and demand for services. 
Therefore, in addition to sociodemographic factors and geographic accessibility that we have 
measured, receipt of appropriate treatment can also depend on a host of individual and 
system level factors such as referral patterns, health literacy, patient preferences, and out-of-
pocket costs, which are difficult to measure at the ecologic level. A second limitation is that 
although we mapped gynecologic oncology practices in neighboring states, we did not take 
these practices into account in our calculations of the E2SFCA. Whereas a gynecologic 
oncologist in a bordering state may be closer for some patients, their access to that specialist 
may be limited by their health insurance network coverage or higher cost for out of network 
care. Finally, our travel zones were based on driving distance and did not take into account 
barriers or benefits posed by access limited to public transportation.
Results from this study will inform ongoing research on the application of GIS methods to 
spatial and sociodemographic factors and add to our understanding of contextual barriers to 
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optimal treatment. In the future, access to specialist services such as gynecologic oncologists 
will become increasingly important as demand for oncologic services is expected to 
significantly outpace supply of oncologists by 2020 (30). Thus, combined geographic and 
sociodemographic analyses can identify areas of particular need for healthcare services as 
well as provide information that may aid in the planning and evaluation of these services.
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Figure 1. 
Geospatial accessibility and vulnerability. (A) E2SFCA accessibility score; (B) social 
vulnerability.
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Figure 2. 
Geosocial vulnerability with higher than expected mortality.
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Figure 3. 
Ovarian cancer mortality in Georgia. (A) Raw mortality rates and (B) empirical Bayes 
smoothed mortality rates with higher than expected mortality measured by Poisson 
possibility.
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